Company Filing History:
7 out of 27 
1 out of 260 
1 out of 1,338 
Years Active: 2012-2018
Title: Daekyung Koh: Innovator in Gene Therapy
Introduction
Daekyung Koh is a prominent inventor based in Yongin-si, South Korea. He has made significant contributions to the field of gene therapy, holding a total of seven patents. His work focuses on developing safe and effective therapeutic agents using adenoviruses.
Latest Patents
Among his latest patents is a novel hexon isolated from simian adenovirus serotype 19. This invention includes a hypervariable region and a chimeric adenovirus that utilizes the same. The therapeutic use of this hexon addresses critical safety and efficacy issues in the development of gene therapeutic agents using adenoviruses. The polynucleotide defined as SEQ ID NO: 3 plays a crucial role in this innovation.
Career Highlights
Daekyung Koh has worked with notable organizations such as Mogam Biotechnology Research Institute and The Green Cross Corporation. His experience in these institutions has allowed him to advance his research and contribute to the field of biotechnology significantly.
Collaborations
Some of his notable coworkers include Seongtae Yun and Kyuhyun Lee. Their collaborative efforts have further enhanced the research and development of innovative solutions in gene therapy.
Conclusion
Daekyung Koh's work in gene therapy exemplifies the impact of innovation in medical science. His patents and collaborations reflect a commitment to improving therapeutic strategies using adenoviruses.